← Back to Search

Vitamin Supplement

Reference dose for 25-Hydroxyvitamin D Levels and Well-being

N/A
Waitlist Available
Led By Pierre Geoffroy, MD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
No Placebo-Only Group

Summary

The investigators hypotheses is that the consumption of the investigators vitamin D fortified cheese will result in an increase in serum 25-hydroxy vitamin D levels in older institutionalized adults. Also, the consumption of the cheese with the higher amount of vitamin D will result in an improvement in wellbeing scores.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The bioavailability of vitamin D from cheddar cheese fortified with vitamin D, in older institutionalized adults
Secondary study objectives
A change in wellbeing scores using an SF-36 survey in the older institutionalized adults

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Reference doseActive Control1 Intervention
Group II: High doseActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
714 Previous Clinical Trials
1,022,794 Total Patients Enrolled
Pierre Geoffroy, MDPrincipal InvestigatorAurora Retirement Centre
Reinhold Vieth, PhD,FCACBPrincipal InvestigatorU of Toronto, Mount Sinai Hospital
~2 spots leftby Nov 2025